Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anil Tulpule

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of responseAlexandra M Levine, Anil Tulpule, Byron Espina, et al.
Blood|May 6, 2010
Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcomaRen Liu, Ming Gong, Xiuqing Li, et al.
Leukemia Research|January 5, 2002
Multidrug resistance (MDR-1) expression in AIDS-related lymphomasAnil Tulpule, Andy Sherrod, Dharshika Dharmapala, et al.
American Journal of Clinical Pathology|March 13, 2014
p53 expression is a strong marker of inferior survival in de novo diffuse large B-cell lymphoma and may have enhanced negative effect with MYC coexpression: a single institutional clinicopathologic studyYi Xie, Mohmad Ajaz Bulbul, Lingyun Ji, et al.
Blood|December 8, 2009
KSHV-induced notch components render endothelial and mural cell characteristics and cell survivalRen Liu, Xiuqing Li, Anil Tulpule, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2008
Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphomaK Sue Robinson, Michael E Williams, Richard H van der Jagt, et al.
Cancer|July 13, 2002
Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcomaAnil Tulpule, Jerome Groopman, M Wayne Saville, et al.
Cancer|June 22, 2010
Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapyMary Cianfrocca, Sandra Lee, Jamie Von Roenn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2006
Phase I study of antisense oligonucleotide against vascular endothelial growth factor: decrease in plasma vascular endothelial growth factor with potential clinical efficacyAlexandra M Levine, Anil Tulpule, David I Quinn, et al.
Clinical Lymphoma & Myeloma|August 2, 2006
Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphomaAnil Tulpule, Byron M Espina, Nancy Berman, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of responseAlexandra M Levine, Anil Tulpule, Byron Espina, et al.
Blood|May 6, 2010
Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcomaRen Liu, Ming Gong, Xiuqing Li, et al.
Leukemia Research|January 5, 2002
Multidrug resistance (MDR-1) expression in AIDS-related lymphomasAnil Tulpule, Andy Sherrod, Dharshika Dharmapala, et al.
American Journal of Clinical Pathology|March 13, 2014
p53 expression is a strong marker of inferior survival in de novo diffuse large B-cell lymphoma and may have enhanced negative effect with MYC coexpression: a single institutional clinicopathologic studyYi Xie, Mohmad Ajaz Bulbul, Lingyun Ji, et al.
Blood|December 8, 2009
KSHV-induced notch components render endothelial and mural cell characteristics and cell survivalRen Liu, Xiuqing Li, Anil Tulpule, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2008
Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphomaK Sue Robinson, Michael E Williams, Richard H van der Jagt, et al.
Cancer|July 13, 2002
Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcomaAnil Tulpule, Jerome Groopman, M Wayne Saville, et al.
Cancer|June 22, 2010
Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapyMary Cianfrocca, Sandra Lee, Jamie Von Roenn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2006
Phase I study of antisense oligonucleotide against vascular endothelial growth factor: decrease in plasma vascular endothelial growth factor with potential clinical efficacyAlexandra M Levine, Anil Tulpule, David I Quinn, et al.
Clinical Lymphoma & Myeloma|August 2, 2006
Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphomaAnil Tulpule, Byron M Espina, Nancy Berman, et al.
Pageof 3